Glucotrack (GCTK) Gains from Investment Securities (2012 - 2018)
Glucotrack's (GCTK) quarterly Gains from Investment Securities came in at $6.9 million in Q4 2018, up 25869.27% YoY from N/an in Q4 2017, and up 7566.91% on a QoQ basis from -$91762.0 in Q3 2018.
Glucotrack (GCTK) Gains from Investment Securities (2012 - 2018) Analysis & Trends
Glucotrack (GCTK) has 7 years of Gains from Investment Securities data on file, last reported at $6.9 million in Q4 2018.
- Quarterly Gains from Investment Securities rose 25869.27% year-over-year to $6.9 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $6.6 million (up 2297.64% YoY) and the FY2018 annual result came in at $6.6 million, up 2297.64% from the prior year.
- Gains from Investment Securities climbed to $6.9 million in Q4 2018, from -$91762.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $6.9 million in Q4 2018 to a low of -$6.1 million in Q2 2014.
- A 5-year average of -$16135.8 and a median of -$65770.0 in 2015 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2014 — Gains from Investment Securities tumbled 2692.79% — and 2018, when it jumped 25869.27%.
- Tracing GCTK's Gains from Investment Securities over 5 years: stood at -$50635.0 in 2014, then soared by 45.02% to -$27839.0 in 2015, then plunged by 66.26% to -$46286.0 in 2016, then soared by 42.55% to -$26589.0 in 2017, then jumped by 25869.27% to $6.9 million in 2018.
- The last three Gains from Investment Securities figures came in at $6.9 million (Q4 2018), -$91762.0 (Q3 2018), and -$82081.0 (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Glucotrack | 1.68 Mn | 553,542.53 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 6.85 Mn |
| Dec 31, 2018 | 6.85 Mn |
| Sep 30, 2018 | -91,762.00 |
| Sep 30, 2018 | -91,762.00 |
| Jun 30, 2018 | -82,081.00 |
| Jun 30, 2018 | -82,081.00 |
| Mar 31, 2018 | -77,947.00 |
| Mar 31, 2018 | -77,947.00 |
| Dec 31, 2017 | -26,589.00 |
| Dec 31, 2017 | -26,589.00 |
| Sep 30, 2017 | -82,658.00 |
| Sep 30, 2017 | -82,658.00 |
| Jun 30, 2017 | -106,976.00 |
| Jun 30, 2017 | -106,976.00 |
| Mar 31, 2017 | -84,099.00 |
| Mar 31, 2017 | -84,099.00 |
| Sep 30, 2016 | -46,286.00 |
| Sep 30, 2016 | -46,286.00 |
| Jun 30, 2016 | -20,702.00 |
| Jun 30, 2016 | -20,702.00 |